Cernostics’ latest clinical validation paper evaluated the performance of its TissueCypher in detecting prevalent esophageal cancer otherwise missed by standard pathology. Images from the study appear on the cover of the February issue of the journal Cancer Epidemiology Biomarkers and Prevention: http://bit.ly/2k3cNVn
Client & Alumni News
Cernostics on Cover of AACR Journal
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.